Home › Trial NCT03165994
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
- Trial IDNCT03165994
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorApexigen America, Inc.
- Enrollment34
- Start date2017-10-06
- ConditionsEsophageal Cancer · GastroEsophageal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.